Cargando…

Subjective Sleep Quality as it Relates to Cognitive and Physical Function in Spinal Muscular Atrophy Patients

Sleep quality and its association with cognition has been widely studied in some neurodegenerative diseases, but less is known about this association in spinal muscular atrophy (SMA). In adult SMA (n = 21) patients and age-matched controls (n = 23), we assessed subjectively measured sleep quality an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wennberg, Alexandra, Lenzoni, Sabrina, Turcano, Pierpaolo, Casagrande, Elena, Caumo, Luca, Sorarú, Gianni, Pegoraro, Elena, Semenza, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357184/ https://www.ncbi.nlm.nih.gov/pubmed/37182894 http://dx.doi.org/10.3233/JND-221627

Ejemplares similares

The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA)
por: Blasi, Lorenzo, et al.
Publicado: (2023)

Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients
por: Borgia, Doriana, et al.
Publicado: (2017)

Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies
por: Bello, Luca, et al.
Publicado: (2016)

Muscle MRI and functional outcome measures in Becker muscular dystrophy
por: Barp, Andrea, et al.
Publicado: (2017)

Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients
por: Querin, Giorgia, et al.
Publicado: (2016)

Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes
por: Milioto, Carmelo, et al.
Publicado: (2017)

Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
por: Lombardi, Vittoria, et al.
Publicado: (2019)

Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy
por: Bello, Luca, et al.
Publicado: (2016)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Nusinersen improves walking distance and reduces fatigue in later‐onset spinal muscular atrophy
por: Montes, Jacqueline, et al.
Publicado: (2019)

Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease
por: Finsterer, Josef, et al.
Publicado: (2017)

Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease
por: Finsterer, Josef, et al.
Publicado: (2017)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Cardiac involvement in patients with Spinal Muscular Atrophies
por: Palladino, Alberto, et al.
Publicado: (2011)

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2018)

Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy
por: Orbach, Rotem, et al.
Publicado: (2022)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Enhanced Neural Empathic Responses in Patients with Spino-Bulbar Muscular Atrophy: An Electrophysiological Study
por: Palmieri, Arianna, et al.
Publicado: (2020)

Developmental milestones in type I spinal muscular atrophy
por: De Sanctis, Roberto, et al.
Publicado: (2016)

Comprehensive assessment model for patients with spinal muscular atrophy: proposal of tools for clinical practice and real-world studies
por: Alves, Renalli Manuella Rodrigues, et al.
Publicado: (2023)

Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy
por: Lusakowska, Anna, et al.
Publicado: (2021)

Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States
por: Darras, Basil T., et al.
Publicado: (2022)

Recent Progress in the Identification of the X-Linked Infantile Spinal Muscular Atrophy (Xl-SMA) Gene: Implications for Neuronal Apoptosis
por: Baumbach, L. L., et al.
Publicado: (2001)

Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review Study
por: Elman, Lauren, et al.
Publicado: (2022)

Mitochondrial abnormalities in spinal and bulbar muscular atrophy
por: Ranganathan, Srikanth, et al.
Publicado: (2009)

Rapid molecular diagnosis of spinal muscular atrophy
por: Mittal, Balraj
Publicado: (2012)

Clinical features of spinal and bulbar muscular atrophy
por: Rhodes, Lindsay E., et al.
Publicado: (2009)

Disease burden of spinal muscular atrophy in Germany
por: Klug, Constanze, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_42map9tik001hu4r1hn88m0fqt